- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- monomer
- Ligands
- 1 x VBF: 3-[2-azanyl-6-[2-oxidanylidene-1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]pyridin-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 18 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.3: 5 residues within 4Å:- Chain A: P.403, I.406, I.407, F.410, L.424
Ligand excluded by PLIPOLA.4: 8 residues within 4Å:- Chain A: Y.51, V.54, S.55, K.130, W.137
- Ligands: OLA.5, OLA.13, OLA.21
Ligand excluded by PLIPOLA.5: 6 residues within 4Å:- Chain A: C.36, W.40, A.58, A.62
- Ligands: OLA.4, OLA.12
Ligand excluded by PLIPOLA.6: 11 residues within 4Å:- Chain A: V.65, P.69, F.70, T.73, F.78, A.80, A.81, I.88, Q.171
- Ligands: OLA.16, OLA.22
Ligand excluded by PLIPOLA.7: 8 residues within 4Å:- Chain A: F.101, W.151, N.183, F.188, A.192, C.193
- Ligands: OLA.9, OLA.17
Ligand excluded by PLIPOLA.8: 4 residues within 4Å:- Chain A: L.200, G.203, V.204, R.207
Ligand excluded by PLIPOLA.9: 4 residues within 4Å:- Chain A: N.183, Y.187, A.192
- Ligands: OLA.7
Ligand excluded by PLIPOLA.10: 10 residues within 4Å:- Chain A: L.27, L.30, G.31, L.34, P.440, F.441, A.444, F.454, R.455, I.458
Ligand excluded by PLIPOLA.12: 6 residues within 4Å:- Chain A: V.33, C.36, W.37, W.40, V.65
- Ligands: OLA.5
Ligand excluded by PLIPOLA.13: 2 residues within 4Å:- Ligands: OLA.4, OLA.21
Ligand excluded by PLIPOLA.14: 7 residues within 4Å:- Chain A: I.18, L.22, I.29, G.64, I.72, S.75, T.76
Ligand excluded by PLIPOLA.15: 4 residues within 4Å:- Chain A: I.18, T.19, L.22, A.23
Ligand excluded by PLIPOLA.16: 6 residues within 4Å:- Chain A: V.65, L.66, F.70, I.88
- Ligands: OLA.6, OLA.22
Ligand excluded by PLIPOLA.17: 7 residues within 4Å:- Chain A: L.139, A.142, I.143, T.146, W.151, F.188
- Ligands: OLA.7
Ligand excluded by PLIPOLA.18: 7 residues within 4Å:- Chain A: L.198, L.199, L.202, K.388, A.391, I.392, V.394
Ligand excluded by PLIPOLA.20: 11 residues within 4Å:- Chain A: F.52, A.105, I.108, D.109, L.123, V.124, R.128, I.132, I.135, C.136, L.139
Ligand excluded by PLIPOLA.21: 8 residues within 4Å:- Chain A: I.133, A.134, W.137, F.141, L.145
- Ligands: OLA.4, OLA.13, OLA.22
Ligand excluded by PLIPOLA.22: 7 residues within 4Å:- Chain A: A.81, H.83, G.84, F.87
- Ligands: OLA.6, OLA.16, OLA.21
Ligand excluded by PLIP- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weng, Y. et al., Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A 2 receptors. Sci China Life Sci (2024)
- Release Date
- 2023-08-16
- Peptides
- Adenosine receptor A2a,Endolysin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- monomer
- Ligands
- 1 x VBF: 3-[2-azanyl-6-[2-oxidanylidene-1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]pyridin-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 18 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weng, Y. et al., Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A 2 receptors. Sci China Life Sci (2024)
- Release Date
- 2023-08-16
- Peptides
- Adenosine receptor A2a,Endolysin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.